Jill Moormeier
Impact in
-
- Global Cancer Incidence and Screening
- Viral-associated cancers and disorders
- Cancer Risks and Factors
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Co-authors
- Stephanie Williams (4 shared papers)Harvey M. Golomb (5 shared papers)Nisreen Haideri (2 shared papers)Rosemarie Mick (2 shared papers)Bitran Jd (1 shared paper)Ralph R. Weichselbaum (4 shared papers)Mark J. Ratain (3 shared papers)A. Awan (2 shared papers)
- Journals
- Annals of Surgical Oncology (3 papers)JNCI Journal of the National Cancer Institute (2 papers)Journal of Clinical Oncology (2 papers)Hematology/Oncology Clinics of North America (1 paper)Blood (1 paper)
- Partner nations
- United StatesThailandAustralia
In The Last Decade
Jill Moormeier
24 papers receiving 482 citations
Peers
Comparison fields: 5 of 76
- Oncology 202
- Genetics 73
- Pathology and Forensic Medicine 119
- Hematology 43
- Otorhinolaryngology 12
Countries citing papers authored by Jill Moormeier
This map shows the geographic impact of Jill Moormeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Moormeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Moormeier more than expected).
Fields of papers citing papers by Jill Moormeier
This network shows the impact of papers produced by Jill Moormeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Moormeier. The network helps show where Jill Moormeier may publish in the future.
Co-authors
The 25 scholars most cited alongside Jill Moormeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 132 | |
| 2 | Mitoxantrone: potential for use in intensive therapy. | 1990 | 71 |
| 3 | High-dose combination chemotherapy with thiotepa and autologous hematopoietic stem cell reinfusion in the treatment of patients with relapsed refractory lymphomas. | 1990 | 44 |
| 4 | 2011 | 30 | |
| 5 | 1989 | 28 | |
| 6 | 1991 | 27 | |
| 7 | 1993 | 25 | |
| 8 | 2014 | 23 | |
| 9 | 1990 | 23 | |
| 10 | 1989 | 23 | |
| 11 | 1992 | 19 | |
| 12 | 2016 | 9 | |
| 13 | 1989 | 8 | |
| 14 | 2009 | 7 | |
| 15 | 1991 | 7 | |
| 16 | 1989 | 7 | |
| 17 | 1990 | 7 | |
| 18 | 2022 | 6 | |
| 19 | 2020 | 5 | |
| 20 | 2022 | 5 |
About Jill Moormeier
Jill Moormeier is a scholar working on Oncology, Genetics, Pathology and Forensic Medicine, Surgery and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 512 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Global Cancer Incidence and Screening (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Diagnosis and Treatment (2 papers), Viral-associated cancers and disorders (2 papers), Immune Cell Function and Interaction (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Oncology (202 citations), Genetics (73 citations), Pathology and Forensic Medicine (119 citations), Hematology (43 citations) and Otorhinolaryngology (12 citations). Jill Moormeier has collaborated with scholars based in United States, Thailand and Australia. Frequent co-authors include Stephanie Williams, Harvey M. Golomb, Nisreen Haideri, Rosemarie Mick, Bitran Jd, Ralph R. Weichselbaum, Mark J. Ratain, A. Awan, Harry W. Schoenberg and Gerald W. Chodak. Their work appears in journals such as Annals of Surgical Oncology, JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology, Hematology/Oncology Clinics of North America and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.